Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

Article Abstract:

Immunohistochemical analysis is used to determine the expression of the excision repair cross-complementation group 1 (ERCC1) protein in operative specimens of non-small-cell lung cancer through comparison of the effect of adjuvant cisplatin-based chemotherapy on survival. Patients with completely resected non-small-cell lung cancer and ERCC1-negative tumors appear to benefit from adjuvant cisplatin-based chemotherapy, whereas patients with ERCC1-positive tumors do not.

Author: Tursz, Thomas, Sabatier, Laure, Pignon, Jean-Pierre, Soria, Jean-Charles, Olaussen, Ken A., Dunant, Ariane, Fouret, Pierre, Brambilla, Elisabeth, Andre, Febrica, Haddad, Vincent, Taranchon, Estelle, Filipits, Martin, Pirker, Robert, Popper, Helmut H., RolfStahel, M.D., Le Chevalier, Thierry
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
Genetic aspects, Chemotherapy, Lung cancer, Non-small cell, Non-small cell lung cancer, Cisplatin

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Tyrosine Kinases as targets for cancer therapy

Article Abstract:

Protein Tyrosine Kinases (TKs) are enzymes that catalyze the transfer of phosphate from ATP to tyrosine residues in polypeptides. The mechanisms of aberrant TK signaling and strategies to inhibit TKs in cancer are reviewed, the status of TK-directed cancer therapies is summarized, and the challenges and prospects for the future are discussed.

Author: Krause, Daniela S., Etten, Richard A. Van
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
Methods, Protein kinases, New England

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Curing Cancer with p53

Article Abstract:

The activity of p53 tumor suppressor protein plays an important role in controlling cancer. Such a progress will further encourage the investment needed to support clinical trials.

Author: Lane, David
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
Clinical trials

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Research, Cancer, Cancer treatment
Similar abstracts:
  • Abstracts: Regionalization of high-risk surgery and implications for patient travel times. Disparities in the utilization of high-volume hospitals for complex surgery
  • Abstracts: Clues to gene activity in inflammation found. Progress in antisense technology
  • Abstracts: Two steps forward in the treatment of Colorectal Cancer.. Surveillance strategies after curative treatment of Colorectal Cancer
  • Abstracts: A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2021 Advameg, Inc.